New pain combo for diabetic nerve pain falls flat before starting
NCT ID NCT06715462
First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study was designed to test a new drug called N0750 for people with painful diabetic peripheral neuropathy (nerve pain from diabetes). It aimed to compare N0750 against two standard pain medications, Cymbalta and Lyrica, over 12 weeks. However, the trial was withdrawn before any participants enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eurofarma Laboratórios S.A
Itapevi, São Paulo, 06696-000, Brazil
Conditions
Explore the condition pages connected to this study.